Demand for Virtual Healthcare Grew 120% Amid Pandemic, ISG Analysis Finds
June 08 2021 - 10:03AM
Business Wire
ISG TechXchange event to explore shifts in
healthcare and life sciences demand and delivery with speakers from
Nuance, Mathematica, Bayer, Takeda, PPD, Hims & Hers and
more
The number of healthcare services contracts with virtual
healthcare delivery components increased 120 percent between 2019
and 2020, signaling a long-term shift in consumer demand that is
attracting new entrants from outside the industry ecosystem,
according to new market analysis from Information Services Group
(ISG) (Nasdaq: III), a leading global technology research and
advisory firm.
These and other insights into the changing dynamics of the
healthcare and life sciences industries will be discussed during
the virtual ISG TechXchange: Health Sciences event, June 22–23.
Leaders from Nuance, Mathematica, Bayer, Takeda, PPD, Hims &
Hers and more will explore shifting provider ecosystems and user
expectations, new patient-centric approaches, interoperability and
connected care, and pandemic-induced innovation.
“Virtual care exploded during the pandemic and it is here to
stay, delivering significant benefits to providers and patients,”
said Bob Krohn, partner and lead of the ISG Healthcare unit and
co-host of the ISG TechXchange. “Demand for digital capabilities
such as connected healthcare monitoring devices and telehealth will
continue to accelerate. Healthcare payers must rethink traditional
assumptions, build solid data management and integration
capabilities, stay abreast of laws and regulations and make
permanent changes in their business models.”
The changing landscape of digital healthcare services is also
attracting notable entrants from outside the traditional healthcare
ecosystem, Krohn noted. The April announcement that Microsoft
intends to acquire Nuance Communications is part of an ongoing race
among major technology companies to build and buy machine
learning-based software and services to stay at the forefront of
the artificial intelligence revolution.
Peter Durlach, executive vice president and chief strategy
officer of Nuance Communications, will participate in a fireside
chat, “Building Healthcare’s Digital Front Door,” describing the
vision, technologies and tools behind Nuance’s AI-powered patient
engagement platform that will transform access and delivery of care
in the age of digital medicine.
Among other speakers, Matt Gillingham, vice president and chief
technology officer of Mathematica, will deliver a keynote
presentation on the value of clinical content expertise in
healthcare data science, and Dr. Patrick Carroll, chief medical
officer of Hims & Hers, which connects consumers with licensed
medical professionals, will deliver a keynote presentation on
direct-to-consumer health. The role of technology in the future of
healthcare will be the topic of a keynote presentation by Dr.
Robert Pearl, former CEO of The Permanente Medical Group and author
of Mistreated: Why We think We’re Getting Good Healthcare—And Why
We’re Usually Wrong.
Jenn Stein, partner and leader of the ISG Life Sciences unit and
co-host of the event, will host fireside chats with Melissa Saw,
director of marketing procurement for Bayer, on how the
pharmaceutical industry achieved the seemingly impossible over the
past year, and with Nik Morton, senior vice president of digital
services for global contract research organization PPD, on adopting
automation technologies.
“Just as enterprises across the health sciences ecosystem are
seeking to leverage technology, regulatory authorities now
recognize digital transformation as a mechanism to modernize drug
and device development processes,” Stein said. “Automation,
artificial intelligence, machine learning, natural language
processing and data analytics can empower health sciences
regulatory authorities to achieve their primary objectives of
ensuring patient health, safety and manufacturer compliance in
increasingly powerful ways.”
Additional speakers will include Joel Tucker and Pat Fuller of
Takeda Pharmaceuticals, who will share Takeda’s work to create a
consolidated, harmonized IT infrastructure that simplifies user
experience while streamlining IT operations and reducing costs.
The ISG TechXchange: Health Sciences event is sponsored by
Capgemini, GAVS and Genpact. More information and registration are
available on the event website.
About ISG
ISG (Information Services Group) (Nasdaq: III) is a leading
global technology research and advisory firm. A trusted business
partner to more than 700 clients, including more than 75 of the
world’s top 100 enterprises, ISG is committed to helping
corporations, public sector organizations, and service and
technology providers achieve operational excellence and faster
growth. The firm specializes in digital transformation services,
including automation, cloud and data analytics; sourcing advisory;
managed governance and risk services; network carrier services;
strategy and operations design; change management; market
intelligence and technology research and analysis. Founded in 2006,
and based in Stamford, Conn., ISG employs more than 1,300
digital-ready professionals operating in more than 20 countries—a
global team known for its innovative thinking, market influence,
deep industry and technology expertise, and world-class research
and analytical capabilities based on the industry’s most
comprehensive marketplace data. For more information, visit
www.isg-one.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210608005255/en/
Will Thoretz, ISG +1 203 517 3119 will.thoretz@isg-one.com Cait
Buckley, Matter Communications for ISG +1 617 874 5214
isg@matternow.com
Information Services (NASDAQ:III)
Historical Stock Chart
From Aug 2024 to Sep 2024
Information Services (NASDAQ:III)
Historical Stock Chart
From Sep 2023 to Sep 2024